Literature DB >> 20182797

Views of parents and pharmacists following participation in a paediatric pharmacovigilance study.

Mansour Tobaiqy1, Derek Stewart, Peter J Helms, Christine M Bond, Amanda Jane Lee, James McLay.   

Abstract

OBJECTIVE: To explore the experiences and views of community pharmacists and parents participating in a prospective paediatric pharmacovigilance study.
METHOD: Twenty-five pharmacists and 32 parents were approached for telephone interview. Interviews were audio-recorded, transcribed and analysed thematically to identify recurring issues and themes.
RESULTS: Seventeen pharmacists and 22 parents were interviewed. Parents and pharmacists agreed that more information about the side effects of medicines in children was required. Both groups reported willingness to participate in future prospective pharmacovigilance studies, although pharmacists expressed concerns about the lack of financial incentives. Pharmacists reported that parents had concerns regarding the confidentiality of their child's ADR data and the study data collection process.
CONCLUSION: This study highlighted positive and negative opinions of parents and pharmacists regarding their experiences in this research project. Maintaining confidentiality in relation to indication and medicines prescribed were important issues for parents whereas time constraints and lack of financial incentives were key issues influencing participation by community pharmacists.

Entities:  

Mesh:

Year:  2010        PMID: 20182797     DOI: 10.1007/s11096-010-9374-0

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  12 in total

1.  Under-reporting of adverse drug reactions. Estimate based on a spontaneous reporting scheme and a sentinel system.

Authors:  A Alvarez-Requejo; A Carvajal; B Bégaud; Y Moride; T Vega; L H Arias
Journal:  Eur J Clin Pharmacol       Date:  1998-08       Impact factor: 2.953

2.  Sampling for qualitative research.

Authors:  M N Marshall
Journal:  Fam Pract       Date:  1996-12       Impact factor: 2.267

3.  Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom.

Authors:  K J Belton; S C Lewis; S Payne; M D Rawlins; S M Wood
Journal:  Br J Clin Pharmacol       Date:  1995-03       Impact factor: 4.335

4.  Experiences of stigma among outpatients with schizophrenia.

Authors:  Faith B Dickerson; Jewel Sommerville; Andrea E Origoni; Norman B Ringel; Frederick Parente
Journal:  Schizophr Bull       Date:  2002       Impact factor: 9.306

5.  A prospective questionnaire assessment of attitudes and experiences of off label prescribing among hospital based paediatricians.

Authors:  J S McLay; M Tanaka; S Ekins-Daukes; P J Helms
Journal:  Arch Dis Child       Date:  2006-01-27       Impact factor: 3.791

6.  Monitoring adverse drug reactions in children using community pharmacies: a pilot study.

Authors:  Derek Stewart; Peter Helms; Dorothy McCaig; Christine Bond; James McLay
Journal:  Br J Clin Pharmacol       Date:  2005-06       Impact factor: 4.335

7.  Paediatric adverse drug reaction reporting: understanding and future directions.

Authors:  Bruce C Carleton; M Anne Smith; Michaela N Gelin; Susan C Heathcote
Journal:  Can J Clin Pharmacol       Date:  2007-02-12

8.  A pilot study to evaluate a community pharmacy-based monitoring system to identify adverse drug reactions associated with paediatric medicines use.

Authors:  Mansour Tobaiqy; Derek Stewart; Peter J Helms; Christine Bond; Amanda Jane Lee; Nick Bateman; Dorothy McCaig; James McLay
Journal:  Eur J Clin Pharmacol       Date:  2010-03-02       Impact factor: 2.953

9.  Direct reporting of suspected adverse drug reactions by patients.

Authors:  Imti Choonara
Journal:  J R Soc Med       Date:  2004-07       Impact factor: 18.000

10.  Pharmacists' views on involvement in pharmacy practice research: Strategies for facilitating participation.

Authors:  Carol Armour; Martha Brillant; Ines Krass
Journal:  Pharm Pract (Granada)       Date:  2007
View more
  2 in total

1.  Parental reporting of adverse drug reactions associated with attention-deficit hyperactivity disorder (ADHD) medications in children attending specialist paediatric clinics in the UK.

Authors:  Mansour Tobaiqy; Derek Stewart; Peter J Helms; Justin Williams; Jackie Crum; Christopher Steer; James McLay
Journal:  Drug Saf       Date:  2011-03-01       Impact factor: 5.606

2.  What can we learn from parents about enhancing participation in pharmacovigilance?

Authors:  Janine Arnott; Hannah Hesselgreaves; Anthony J Nunn; Matthew Peak; Munir Pirmohamed; Rosalind L Smyth; Mark A Turner; Bridget Young
Journal:  Br J Clin Pharmacol       Date:  2013-04       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.